Cullen/Frost Bankers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$515K Buy
7,644
+66
+0.9% +$4.4K 0.01% 440
2026
Q1
$476K Buy
7,578
+558
+8% +$38.9K 0.01% 435
2025
Q4
$466K Buy
7,020
+1,890
+37% +$122K 0.01% 435
2025
Q3
$345K Sell
5,130
-1,150
-18% -$91K ﹤0.01% 454
2025
Q2
$548K Buy
6,280
+1,370
+28% +$107K 0.01% 398
2025
Q1
$335K Buy
4,910
+59
+1% +$4.82K ﹤0.01% 447
2024
Q4
$377K Buy
4,851
+2,679
+123% +$198K 0.01% 420
2024
Q3
$146K Buy
2,172
+2,094
+2,685% +$172K ﹤0.01% 548
2024
Q2
$8.84K Buy
78
+42
+117% +$5.31K ﹤0.01% 860
2024
Q1
$4.99K Buy
36
+12
+50% +$1.51K ﹤0.01% 862
2023
Q4
$2.98K Buy
+24
New +$2.45K ﹤0.01% 914
2023
Q2
Sell
-12
Closed -$1.39K 1165
2023
Q1
$1.39K Buy
+12
New +$1.34K ﹤0.01% 1120
2022
Q4
Sell
-20
Closed -$2K 1131
2022
Q3
$2K Buy
+20
New +$1.69K ﹤0.01% 1046
2020
Q4
Sell
-8
Closed -$1K 1085
2020
Q3
$1K Buy
8
+4
+100% +$418 ﹤0.01% 1074
2020
Q2
$0 Buy
+4
New +$358 ﹤0.01% 1104
2020
Q1
Sell
-12
Closed -$1K 931
2019
Q4
$1K Buy
+12
New +$569 ﹤0.01% 1013

Other funds holding DXCM

Cullen/Frost Bankers's DXCM Position: Q2 2026 in Review

Cullen/Frost Bankers increased its DexCom (DXCM) stake by 0.87% in Q2 2026, buying an estimated $4.4K and bringing the position to 7,644 shares worth $515K. The position accounts for 0.01% of the portfolio, ranked #440.

Cullen/Frost Bankers first reported a position in DXCM in Q4 2019 and has held it in 16 quarters since. The position peaked at $548K in Q2 2025. 496 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cullen/Frost Bankers held 7,644 shares of DexCom worth $515K as of Q2 2026.
  • Cullen/Frost Bankers bought 66 DexCom shares in Q2 2026, an estimated $4.4K.
  • DexCom made up 0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #440 holding.
  • Cullen/Frost Bankers first reported a position in DexCom in Q4 2019 and has held it in 16 quarters since.
  • Cullen/Frost Bankers's DexCom position peaked at $548K in Q2 2025.
  • 496 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.